USP27通过duebiquitination稳定PFKFB3,促进葡萄糖分解和肝细胞癌的进展
Longhui Xie1, Dekun Song2, Zhengsheng Ouyang3
1Department of Hepatobiliary Pancreatic Spleen Surgery, The Central Hospital of Yongzhou, Yongzhou 425000, PR China.
这项研究表明,USP27通过增强糖解促进肝细胞癌 (HCC) 的生长. 针对CTCF/USP27/PFKFB3通路提供了一个潜在的新策略来治疗HCC和减少转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 肝细胞癌 (HCC) 由于频繁的转移和复发,预后不好.
- 代谢重编程,特别是糖分分解的增加,是癌症进展的标志.
研究的目的:
- 为了确定HCC中糖解的关键调节者.
- 阐明链接转录调节和HCC中的代谢重编程的分子机制.
主要方法:
- 研究了USP27在HCC糖解中的作用.
- 在HCC细胞系中利用基因敲除和过度表达.
- 进行了体内研究,以评估瘤生长和转移.
- 分析了CTCF,USP27和PFKFB3.3之间的相互作用.
主要成果:
- USP27被确定为HCC中糖解的关键调节剂.
- USP27通过二基化稳定了PFKFB3,增加了糖解活性.
- 通过对其发起人进行约束,CTCF直接对USP27的表达进行了升级.
- 击败USP27或CTCF抑制了HCC细胞糖解和增殖.
- 在体内,USP27 Knockdown 抑制了 HCC 的生长和转移.
结论:
- CTCF/USP27/PFKFB3轴代表了一种新的机制,通过增强的糖解驱动HCC的进展.
- 准USP27介导的代谢途径为HCC治疗提供了一个有前途的治疗策略.
更多相关视频
08:29SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
